انتقل إلى المحتوى
Peerford
تسجيل الدخول
Luteolin offers novel therapeutic regimen in rotenone-induced Parkinson disease via modulation of TNF-α/FXMRP/serotonin/tyrosine hydroxylase signaling pathway. · Peerford